FINWIRES · TerminalLIVE
FINWIRES

多伦多证券交易所午盘上涨455点,医疗保健和原材料板块表现最佳。

By

-- 多伦多证券交易所午盘上涨455点,部分收复了此前连续五个交易日下跌630点的部分失地。 表现最佳的板块是医疗保健(+3.6%)和原材料(+2.3%)。博士伦健康(BHC.TO)周三收盘后公布的盈利超出预期,股价上涨近10%,至8.41加元。 加拿大统计局今日公布的数据显示,2月份加拿大实际GDP增长0.2%,而3月份和第一季度的初步数据显示,加拿大经济“远未达到全面复苏状态”。 加拿大帝国商业银行 (CIBC) 的安德鲁·格兰瑟姆 (Andrew Grantham) 表示:“尽管第一季度的增长似乎接近加拿大央行货币政策报告 (MPR) 的预测,但3月份再次出现的停滞令人担忧,因为这关系到春季的增长势头。消费者支出似乎再次放缓,考虑到汽油价格上涨带来的压力以及劳动力市场依然疲软,这种情况是可以理解的。我们仍然认为,经济内部存在足够的闲置产能,即使能源价格上涨的影响在某些领域逐渐显现,也能使核心通胀指标保持相对温和,这将使加拿大央行能够将利率维持在2026年之前不变。” 加拿大国家银行则表示,最新数据显示,尽管面临诸多不利因素,加拿大经济在第一季度依然保持了稳健增长。尽管3月份经济出现预期中的停滞,但按行业划分的GDP显示,今年第一季度按年率计算增长了1.7%。该行指出,19个行业中至少有12个行业在第一季度实现了增长。 “在正常情况下,这样的增长会被认为是可观的,但与此同时,人口却在萎缩,这抑制了经济的潜在GDP增长。因此,人均GDP有望迎来15个季度以来的最强劲增长(年化增长率2.1%)。对于一个供应过剩且失业率高于充分就业水平的经济体来说,这无疑是个好消息。”加拿大国家银行表示。 “然而,”该行补充道,“过去的表现并不能保证未来增长的持续。由于关税的不确定性以及当前的全球地缘政治局势,加拿大经济仍然十分脆弱。虽然大宗商品价格上涨可能对某些行业有利,但潜在的利好将被消费者面临的负面影响所抵消,因为消费者正面临着通胀飙升的困境。全国主要城市中心(包括多伦多和温哥华)房地产市场的疲软正在造成负面的财富效应,这对消费者而言又是一大阻力。” 在股市方面,庞巴迪(BBD-B.TO)股价上涨 17%,至 279.86 美元,此前该公司公布的第一季度盈利超出预期。

Related Articles

Research

Research Alert: The Clorox Company Beats Estimates Driven By Household And International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CLX reported Q3 FY 26 net sales of $1.67B, flat Y/Y with organic sales down 1%, while adj. EPS of $1.64 grew 13% and beat consensus by $0.10. Gross margin contracted 140 bps to 43.2% due to elevated manufacturing costs and unfavorable mix, though disciplined expense management supported earnings. Mixed segment performance showed Household and International delivering growth of 3% and 8%, respectively, while Lifestyle declined 9% on lower consumption and inventory adjustments. Management updated FY 26 guidance expecting net sales to decline ~6% with organic sales down ~9%, including a 7.5%-pt ERP headwind. Adj. EPS guidance of $5.45-$5.65 represents a 27%-29% decline, with gross margin expected to contract 250-300 bps from GOJO inventory step-up and elevated energy costs. The April 1 GOJO acquisition expands the health portfolio though near-term integration costs pressure results. We believe the completed $580M digital transformation positions CLX for long-term operational improvements despite macro headwinds.

$CLX
Research

Research Alert: Rivn: Q1 Eps Ahead Of Consensus; 2026 Guidance Unchanged

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Rivian (RIVN) posted Q1 adjusted EPS of -$0.55 vs. -$0.41, ahead of the -$0.60 consensus. Revenue rose 11% to $1.38B ($10M ahead of consensus) on a 20% increase in total vehicle sales to 10,365 units, augmented by a 49% Y/Y increase in software and services revenue to $473M. RIVN's gross margin contracted 800 bps to 8.6%, but was ahead of the 8.4% consensus. The quarter's financial results reflect the company's strategic pivot toward broader market accessibility with the R2, though at the cost of near-term profitability. RIVN maintained prior 2026 guidance for adjusted EBITDA, vehicle deliveries, and capex. The company ended Q1 with cash of $4.8B, down from $6.1B at year-end 2025. Shares are trading 1% higher in after-hours trading. RIVN's Q1 earnings were ahead of expectations, although cash burn remains a key concern, with free cash flow deteriorating, driven by increased operating expenses and working capital consumption. Execution risks remain high given challenging demand facing the broader EV industry.

$RiVN
Australia

Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased

Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.

$SKT